Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

State of the Art in HIV Drug Resistance: Science and Technology Knowledge Gap.

AIDS reviews - 1 Jan 2000

Boucher Charles A, Bobkova Marina R, Geretti Anna Maria, Hung Chien-Ching, Kaiser Rolf, Marcelin Anne-Geneviève, Streinu-Cercel Adrian, van Wyk Jean, Dorr Pat, Vandamme Anne-Mieke

Abstract excerpt

Resistance to antiretroviral therapy (ART) threatens the efficacy of human immunodeficiency virus type 1 (HIV-1) treatment. We present a review of knowledge gaps in the science and technologies of acquired HIV-1 drug resistance (HIVDR) in an effort to facilitate research, scientific exchange, and progress in clinical management. The expert authorship of this review convened to identify data gaps that exist in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Mutation

Source

Identifiers

PMID: 29628515

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

State of the Art in HIV Drug Resistance: Science and Technology Knowledge Gap.PMID 29628515Read ↗

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA PanelSemantic proximity Read ↗

HIV-1 drug resistance and resistance testing.Semantic proximity Read ↗

HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.Semantic proximity Read ↗

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment FailureSemantic proximity Read ↗

Primary HIV-1 Drug Resistant Minority Variants.Semantic proximity Read ↗

Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptaseSemantic proximity Read ↗

Overview on HIV-1-related drug resistance: from theory to clinical practice.Semantic proximity Read ↗

Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.Semantic proximity Read ↗

The Phenomenon of Antiretroviral Drug Resistance in the Context of Human Immunodeficiency Virus Treatment: Dynamic and Ever Evolving Subject MatterSemantic proximity Read ↗

2017 Update of the Drug Resistance Mutations in HIV-1.Semantic proximity Read ↗

Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.Semantic proximity Read ↗

HIV-1 Drug Resistance Trends in the Era of Modern Antiretrovirals: 2018–2024Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.